What changed in this filing

/stocks — the workspaceLOADING

Item 5. Market for Registrant’s Common Equity

2025-03-27 compared with 2024-03-28 · 30 added, 19 removed, 12 unchanged (80% of the section changed)

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

common stock and Public Warrant commenced trading on The Nasdaq Capital Market under the symbols “WKSP” and “WKSPW,”

respectively, on August 4, 2021.

Prior to trading on Nasdaq, our common stock was quoted on the OTCQB Market under the symbol “WKSP.”

common stock commenced trading on The Nasdaq Capital Market under the symbol “WKSP” on August 4, 2021.

Prior to trading on

Nasdaq, our common stock was quoted on the OTCQB Market under the symbol “WKSP.”

of Common Stock

3 unchanged sentences

Their telephone number is (212) 828-8436.

have never paid any cash dividends on our common stock.

We anticipate that we will retain funds and future earnings to support operations

and to finance the growth and development of our business.

Therefore, we do not expect to pay cash dividends in the foreseeable future.

Any future decision to pay dividends will be at the discretion of our Board and will depend on our financial condition, results of operations,

capital requirements, and other factors that our Board deems relevant.

In addition, the terms of any future debt or credit financings

may preclude us from paying dividends.

do not expect to pay cash dividends in the foreseeable future.

Any future decision to pay dividends will be at the discretion of our

board and will depend, among other things, on earnings, financial condition, level of indebtedness, provisions of our existing credit

agreements and other factors that our board deems relevant.

Sales of Equity Securities

to purchase 770,026 shares of common stock of the Company at an exercise price of $7.40 per share, subject to adjustment for reverse

stock splits, recapitalizations and reorganizations, which are exercisable six months from November 2, 2023, or May 2, 2024, until

the date that is five and a half years from November 2, 2023, or May 7, 2029.

to purchase 7,700,264 shares of common stock of the Company at an exercise price of $0.74 per share, subject to adjustment for reverse

stock splits, recapitalizations and reorganizations, which are exercisable six months after the date of issuance, or September 20,

2024, until the five and a half-year anniversary date of the date of issuance, or September 20, 2029.

foregoing securities were issued in reliance on the exclusion from registration provided by Section 4(a)(2) and/or Rule 506 of Regulation D promulgated under the Securities Act due

to the fact the issuance did not involve a public offering of securities.

May 31, 2024, the Company issued warrants to purchase up to 1,295,000 shares of the Company’s common stock in connection with

entering into the Inducement Offer Letter with a certain holder of existing warrants, pursuant to which the Holder agreed to exercise

for cash its Existing Warrants to purchase an aggregate of 700,000 shares of the Company’s common stock, at a reduced exercised

price of $0.5198 per share.

Each Inducement Warrant has an exercise price equal to $5.198 per share and will be exercisable at any

time on or after the date that is six (6) months from the issuance date provided that stockholder approval is obtained and will have

a term of exercise of five and one half (5½) years following the date of issuance.

The Company engaged Maxim Group LLC (“Maxim”)

to act as its exclusive warrant solicitation agent and financial advisor in connection with the warrant inducement transaction and

paid Maxim a cash fee equal to 7.0% of the gross proceeds received from the exercise of the Existing Warrants.

The Company used and

is expecting to use the net proceeds of these transactions for general corporate purposes, including working capital.

On September 19, 2024, the Company issued 95,000 shares of common stock to an investor at a $0.40 per share purchase price and warrants

to purchase up to 190,000 shares of common stock at an exercise price of $0.40 per share.

The warrants will be exercisable for a period

of five year from the date of issuance.

issuance of the securities listed above was deemed exempt from registration under Section 4(a)(2) of the Securities Act or Regulation D

promulgated thereunder in that the issuance of securities were made to an accredited investor and did not involve a public offering.

The recipient of such securities represented its intention to acquire the securities for investment purposes only and not with a view

to or for sale in connection with any distribution thereof.

Authorized for Issuance Under Equity Compensation Plans

Item 12 “ Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Equity Incentive

Plans ” of this Annual Report on Form 10-K.

“Part III, Item 12, Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Equity

Incentive Plans” of this report which is incorporated herein by reference.

Incentive Plans

Item 11 “ Executive Compensation ” of this Annual Report on Form 10-K.

“Part III Item 11, Executive Compensation” of this report which is incorporated herein by reference.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 5. Market for Registrant’s Common Equity